- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03435497
Pilot Intervention to Empower HIV Clients as Prevention Advocates in Uganda
27. maj 2020 opdateret af: RAND
Game Changers: Pilot Intervention to Empower HIV Clients as Prevention Advocates in Uganda
This randomized controlled pilot study of the "Game Changers" program will:
- Assess the feasibility and acceptability of implementing an HIV prevention advocacy intervention with people living with HIV who are in HIV care, and who will be trained to be advocates of HIV protective behaviors within their social networks.
- Assess preliminary intervention effects on a) protective behavior of the HIV-positive clients (condom use, partner concurrency/number of partners, engagement in HIV care, ART adherence); and b) diffusion of prevention messages across the network, as assessed by the content and extent of communication with network members about protective behaviors (condom use, partner concurrency/number of partners, HIV testing, engagement in HIV care, circumcision), HIV disclosure, and HIV stigma.
- Explore characteristics of HIV-positive clients who more effectively engage in prevention advocacy (in terms of socio-demographics, network characteristics, and network position and type of alters receiving advocacy).
Studieoversigt
Detaljeret beskrivelse
People living with HIV (PLWH) have a critical role to play in HIV prevention, not only in the context of Prevention for Positives and Treatment as Prevention, but as powerful change agents for HIV protective behaviors among others.
Our research suggests that as PLWH receive HIV treatment and restore their health and functioning, many are motivated to protect their loved ones and engage in prevention advocacy (i.e., to encourage friends and family to seek HIV testing and treatment, and to reduce risk behavior); however, the quality of this advocacy is hampered by challenges related to message content, style and timing of delivery, and selection of advocacy recipients.
With effective advocacy training, mobilizing PLWH to be change agents within their social networks has the potential to be a "game changer" for HIV prevention, particularly in high prevalence settings such as Uganda, where virtually every family is touched by someone living with HIV.
Drawing upon theoretical frameworks for network-based interventions, such as theories of social diffusion, cognitive consistency, and social influence, the proposed study will develop and pilot test "Game Changers"-- an intervention that aims to empower and mobilize PLWH to be agents for HIV prevention and behavioral change in their social networks.
In Phase 1, separate focus groups of PLWH and members of their social networks (family and friends) were conducted to explore barriers to and facilitators of mobilizing clients to advocate for HIV prevention, perceptions on how advocacy could be most effective in motivating behavior change, and how to best structure the intervention and its content.
In Phase 2 findings from Phase 1 and network-based intervention models were used to develop the structure and content of an intervention designed to help clients cope with stigma, manage their disease, live positively, and develop motivation and skills for HIV disclosure and prevention advocacy.
In Phase 3 a pilot group intervention will be conducted in a controlled trial of 96 clients, with 48 randomly assigned to receive the intervention and 48 to the wait-list control.
Assessments will be administered to all participants at baseline, 5 months later, and again 8 months after baseline, after which the control group will receive the intervention (but not the interviews).
PLWH interviews and social network assessments will examine intervention effects on protective behaviors of the participant (condom use, HIV treatment adherence), and diffusion of prevention messages across the network, as assessed by the content and extent of communication with network members about protective behaviors (condom use, partner concurrency/number of partners, HIV testing, engagement in HIV care, circumcision), HIV disclosure, and HIV stigma.
At the end of the intervention period a focus group with program participants will be conducted to get feedback on the intervention.
To help understand how participation in the program might affect health, date of HIV diagnosis, last two CD4 counts and HIV viral loads, and prescribed HIV medications will be obtained from PLWH participant medical charts.
Participants (about 15/arm) will be asked to recruit up to 3 alters each, who know the participant's serostatus, to be interviewed to assess their HIV protective behaviors (e.g., condom use) and receipt of prevention advocacy from the intervention participant.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
99
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Kampala, Uganda
- Infectious Diseases Institute
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria (People living with HIV):
- 18+ years old
- In HIV care for > 1 year
- Having disclosed serostatus to at least one person
Inclusion Criteria (Social network members):
- 18+ years old
- Referred by a patient participant because they are family members, friends, or other people in patients' social network
- knows patient participant's serostatus
Exclusion Criteria:
- Individuals who meet the inclusion criteria above will be eligible to participate, and no other exclusion criteria apply.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Game Changers Intervention
Game Changers is an intervention that aims to empower and mobilize people living with HIV to be agents for HIV prevention and behavioral change in their social networks.
|
Game Changers is an intervention that aims to empower and mobilize PLHA to be agents for HIV prevention and behavioral change in their social networks.
|
|
Ingen indgriben: Control
The control group will receive standard of care during the intervention assessment period.
All control participants will be offered the Game Changers program once all assessments for the primary study outcomes have been completed.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Engagement HIV Prevention Advocacy
Tidsramme: Past 3 months, measured at baseline and 5 and 8 months post-baseline
|
Self-reported communication with social network members about protective behaviors.
This is a composite of 14 survey items rated on a scale of 1 (low level of communication) to 5 (high level of communication).
|
Past 3 months, measured at baseline and 5 and 8 months post-baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Sexual Risk Behavior Among Alters
Tidsramme: Measured at baseline and 5 and 8 months post-baseline
|
Increased percentage of self-reported condom use with main partner in past 3 months
|
Measured at baseline and 5 and 8 months post-baseline
|
|
Change in HIV Treatment Adherence
Tidsramme: Measured at baseline and 5 and 8 months post-baseline
|
Increased antiretroviral treatment adherence (self-reported % doses taken in past month)
|
Measured at baseline and 5 and 8 months post-baseline
|
|
Change in Internalized HIV Stigma
Tidsramme: Measured at baseline and 5 and 8 months post-baseline
|
Decreased rates of internalized HIV-related stigma on Internalized AIDS Stigma Scale (range=1-5, higher values = high stigma)
|
Measured at baseline and 5 and 8 months post-baseline
|
|
Number of Participants Who Have Reported Their HIV Status to Their Main Partner
Tidsramme: Measured at baseline and 5 and 8 months post-baseline
|
Increased self-reported rates of HIV status disclosure: Participants were asked if they had disclosed their HIV-serostatus to their main partner or spouse (yes/no).
|
Measured at baseline and 5 and 8 months post-baseline
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
16. april 2018
Primær færdiggørelse (Faktiske)
31. juli 2019
Studieafslutning (Faktiske)
31. juli 2019
Datoer for studieregistrering
Først indsendt
8. februar 2018
Først indsendt, der opfyldte QC-kriterier
14. februar 2018
Først opslået (Faktiske)
19. februar 2018
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
18. juni 2020
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
27. maj 2020
Sidst verificeret
1. maj 2020
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- R34MH111460 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med HIV
-
Duke UniversityGilead SciencesRekrutteringHIV-forebyggelse | HIV præ-eksponeringsprofylakse | HIV forebyggelsesprogram | HIV-forebyggelse og pleje | HIV Pre-eksponering profylakse brugForenede Stater
-
Federal University of São PauloGilead SciencesAfsluttet
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRekrutteringHIV | HIV-testning | HIV-kobling til pleje | HIV behandlingForenede Stater
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RekrutteringHIV-forebyggelse | PrEP overholdelse | HIV-relateret stigmaThailand
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RekrutteringForbered | HIV | HIV-forebyggelse | PrEP optagelseForenede Stater
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RekrutteringGennemførlighed | HIV-forebyggelse | PrEP optagelse | Acceptabilitet | HIV Selvtest | Mandlige partnere af HIV-negative postpartum-kvinderSydafrika
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationAfsluttetPartner HIV-testning | Par HIV Rådgivning | Parkommunikation | HIV-forekomstCameroun, Dominikanske republik, Georgien, Indien
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement og andre samarbejdspartnereUkendtHIV | HIV-uinficerede børn | Børn udsat for HIVCameroun
-
University of MinnesotaTrukket tilbageHIV-infektioner | HIV/AIDS | Hiv | AIDS | Aids/Hiv problem | AIDS og infektionerForenede Stater
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)RekrutteringHIV-forebyggelse | HIV-risikoadfærd | HIV-rådgivning og testningForenede Stater
Kliniske forsøg med Game Changers
-
Ministerio de Salud de Ciudad Autónoma de Buenos...Aktiv, ikke rekrutterendeVacciner mod covid-19Argentina
-
Ministerio de Salud de Ciudad Autónoma de Buenos...RekrutteringVacciner mod covid-19Argentina
-
Ministerio de Salud de Ciudad Autónoma de Buenos...AfsluttetVacciner mod covid-19Argentina
-
Imaging Biometrics, LLCxCuresIkke længere tilgængeligGlioblastom | Glioblastoma Multiforme | Ildfast glioblastomForenede Stater
-
Chang Gung Memorial HospitalTilmelding efter invitation
-
Chang Gung Memorial HospitalAfsluttetSystolisk dysfunktion i venstre ventrikelTaiwan
-
Chang Gung Memorial HospitalTilmelding efter invitation
-
Inner Mongolia Yili Industrial Group Co., LtdAfsluttetDyspepsi | Mavesmerter | Forstoppelse | Luft i mavenKina
-
Chang Gung Memorial HospitalAfsluttet
-
Xiyuan Hospital of China Academy of Chinese Medical...UkendtIkke-erosiv reflukssygdom/diarré irritabel tyktarmKina